First Time Loading...
T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.4 SGD -1.23% Market Closed
Updated: May 7, 2024

Talkmed Group Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Talkmed Group Ltd
Revenue Peer Comparison

Comparables:
P8A
QC7
5NG
1B1
EUDA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
T
Talkmed Group Ltd
SGX:5G3
Revenue
S$83.8m
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Cordlife Group Ltd
SGX:P8A
Revenue
S$55.9m
CAGR 3-Years
3%
CAGR 5-Years
-12%
CAGR 10-Years
3%
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Revenue
S$182.7m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
10%
Healthway Medical Corporation Ltd
SGX:5NG
Revenue
S$160.8m
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
7%
HC Surgical Specialists Ltd
SGX:1B1
Revenue
S$18.6m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Revenue
$9.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Talkmed Group Ltd's Revenue?
Revenue
83.8m SGD

Based on the financial report for Dec 31, 2023, Talkmed Group Ltd's Revenue amounts to 83.8m SGD.

What is Talkmed Group Ltd's Revenue growth rate?
Revenue CAGR 5Y
6%

Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Talkmed Group Ltd have been 10% over the past three years , 6% over the past five years .